New Nusam 400 Tablets contain Ademetionine at a strength of 400mg per tablet. These pharmaceuticals are indicated for the treatment of homocystinuria, a genetic metabolic disorder that affects amino acid metabolism. Ademetionine supplementation helps to correct the imbalance of methionine and homocysteine levels in the body, reducing the risk of complications associated with homocystinuria, such as thromboembolic events, osteoporosis, and mental retardation. New Nusam 400 Tablets should be administered under the supervision of a healthcare professional, and dosage should be individualized based on the patient's age, weight, and response to therapy. Monitoring of blood homocysteine levels is essential during therapy to ensure adequate response and to adjust dosage if necessary. Potential side effects may include gastrointestinal disturbances, liver function abnormalities, and hematologic abnormalities. It is crucial to inform your healthcare provider about any concurrent medications or medical conditions before starting treatment with New Nusam 400 Tablets to minimize risks and maximize treatment efficacy.